Helicobacter pylori is a common chronic gastric infection that provokes persistent gastric inflammation. Several prior studies have proposed links between H. pylori infection and alterations in lipid metabolism, with potential implications for atherosclerosis and cardiovascular risk, but findings across the literature have been inconsistent. This study addresses the relationship between H. pylori serostatus and lipid profiles in a population presenting for general health checkups.
The stated objective was to determine the association between Helicobacter pylori infection and dyslipidemia among individuals attending general health checkups at Tribhuvan University Teaching Hospital (TUTH), Kathmandu, Nepal.
This investigation was a retrospective cross-sectional study conducted at the General Health Checkup (GHC) clinic of TUTH, a tertiary referral center. Data were extracted from pre-existing medical records collected by a physician during routine GHC visits. The authors report ethical clearance from the Institutional Review Committee (IRC IOM TUTH) and that written departmental consent was obtained prior to data collection.
The analytic sample comprised 242 participants with documented H. pylori serological status and available lipid profiles. Participants were grouped by serology into seronegative, equivocal, and seropositive categories. Data collected from records and a pretested standardized questionnaire included demographic characteristics, clinical presentation, medication use, lifestyle factors (including smoking and alcohol consumption), comorbidities, and anthropometric measurements. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared. Lipid parameters and fasting blood sugar (FBS) were recorded from available laboratory results.
The authors report correlation analyses between anthropometric and metabolic variables and lipid parameters. Specific reported correlation coefficients include positive relationships of BMI and body weight with lipid measures. Group comparisons by H. pylori serostatus were used to evaluate differences in FBS and lipid profiles. Exact statistical modelling steps, covariate adjustment methods, or multivariable analyses beyond the reported correlations are not detailed in the abstract.
The sample consisted of 242 participants classified by H. pylori serology into seronegative, equivocal, and seropositive groups. Key reported findings:
BMI correlated positively with LDL (r = 0.208, p = 0.008) and with total cholesterol (r = 0.187, p = 0.017).
Body weight showed a positive correlation with total cholesterol (r = 0.204, p = 0.009).
No significant correlations were observed between fasting blood glucose and lipid parameters in the dataset.
Mean fasting blood glucose did not differ significantly across serostatus groups (FBG: 5.37 ± 1.20 mmol/L in seronegative participants; 5.29 ± 0.93 mmol/L in equivocal participants; 5.56 ± 0.92 mmol/L in seropositive participants; p = 0.347).
The authors interpret these results as indicating an association between H. pylori seropositivity and increased body weight and dyslipidemia, particularly elevated total cholesterol and LDL.
A statistically significant association was observed between male sex and H. pylori seropositivity: 49.1% of the seropositive group were men compared with 26.5% among seronegative participants (p = 0.004). Smoking status did not differ substantially by H. pylori serostatus. Alcohol consumption showed a weak correlation with serostatus that did not reach conventional significance (p = 0.064).
Within the limitations of a retrospective cross-sectional design and reliance on serology from routine clinical records, the study reports that H. pylori seropositivity is associated with higher body weight and with dyslipidemia—specifically higher total cholesterol and LDL levels. The authors highlight the importance of lipid screening and weight reduction strategies in patients identified as H. pylori–positive. The report does not establish causality and does not detail adjusted multivariable analyses in the abstract; such analyses, potential confounding factors, or longitudinal follow-up would be required to support causal inference.
Ethical clearance was obtained from IRC IOM TUTH (Ref no: 56(6-11) E2 76/77) and written departmental consent was obtained prior to data collection. The authors declare no competing interests. Data are available from the authors on request.